Wells Fargo Notes Solid Q3 Results for CVS but Moderates 2025 Bull Case for HCB Segment
CVS Health(US:CVS) Yahoo Finance·2025-12-03 20:11CVS Health Corporation (NYSE:CVS) is included among the 15 Dividend Stocks that Outperform the S&P 500. Wells Fargo Notes Solid Q3 Results for CVS but Moderates 2025 Bull Case for HCB Segment On November 13, Wells Fargo analyst Stephen Baxter lowered the firm’s price target on CVS Health Corporation (NYSE:CVS) to $102 from $103 while maintaining an Overweight rating. The analyst noted that Q3 results were generally solid, though the bullish outlook for the Health Care Benefits (HCB) segment ...